Journal Article

Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders

Toma, Claudio, Schofield, Peter R., Pierce, Kerrie D., Shaw, Alex D., Heath, Anna, Mitchell, Philip B., Fullerton, Janice M.

2018

Overview

The contactin-associated protein-like 2 (CNTNAP2) gene is a member of the neurexin superfamily. CNTNAP2 was first implicated in the cortical dysplasia-focal epilepsy (CDFE) syndrome, a recessive disease characterized by intellectual disability, epilepsy, language impairments and autistic features. Associated SNPs and heterozygous deletions in CNTNAP2 were subsequently reported in autism, schizophrenia and other psychiatric or neurological disorders. We aimed to comprehensively examine evidence for the role of CNTNAP2 in susceptibility to psychiatric disorders, by the analysis of multiple classes of genetic variation in large genomic datasets. In this study we used: i) summary statistics from the Psychiatric Genomics Consortium (PGC) GWAS for seven psychiatric disorders; ii) examined all reported CNTNAP2 structural variants in patients and controls; iii) performed cross-disorder analysis of functional or previously associated SNPs; and iv) conducted burden tests for pathogenic rare variants using sequencing data (4,483 ASD and 6,135 schizophrenia cases, and 13,042 controls). The distribution of CNVs across CNTNAP2 in psychiatric cases from previous reports was no different from controls of the database of genomic variants. Gene-based association testing did not implicate common variants in autism, schizophrenia or other psychiatric phenotypes. The association of proposed functional SNPs rs7794745 and rs2710102, reported to influence brain connectivity, was not replicated; nor did predicted functional SNPs yield significant results in meta-analysis across psychiatric disorders at either SNP-level or gene-level. Disrupting CNTNAP2 rare variant burden was not higher in autism or schizophrenia compared to controls. Finally, in a CNV mircroarray study of an extended bipolar disorder family with 5 affected relatives we previously identified a 131kb deletion in CNTNAP2 intron 1, removing a FOXP2 transcription factor binding site. Quantitative-PCR validation and segregation analysis of this CNV revealed imperfect segregation with BD. This large comprehensive study indicates that CNTNAP2 may not be a robust risk gene for psychiatric phenotypes.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Autism / Autism Spectrum Disorder - genetics / Binding sites / Biology and Life Sciences / Bipolar disorder / Bipolar Disorder - genetics / Brain research / Chromosomes / Contactin / Convulsions & seizures / Cortex / Craniofacial Abnormalities - genetics / Databases, Nucleic Acid / Diagnosis / DNA Copy Number Variations / Dysplasia / Epilepsies, Partial - genetics / Epilepsy / Female / Foxp2 protein / Funding / Gene expression / Genes / Genetic analysis / Genetic diversity / Genetic Predisposition to Disease / Genetics / Genome-Wide Association Study / Genomes / Genomics / Humans / Introns / Language / Male / Malformations of Cortical Development - genetics / Medicine and Health Sciences / Membrane Proteins - genetics / Mental disorders / Mental Disorders - genetics / Mental illness / Mutation / Nerve Tissue Proteins - genetics / Neural networks / Neurological diseases / Neurosciences / Pedigree / Phenotype / Phenotypes / Polymorphism, Single Nucleotide / Proteins / Psychiatry / Risk Factors / Schizophrenia / Schizophrenia - genetics / Sequence Deletion / Single-nucleotide polymorphism / Social Sciences / Software / Statistical analysis / Transcription factors